Leukemia, 0887-6924
Journal
Publications
- Published
The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
Keith Wheatley, 1 Jul 2011, In: Leukemia. 25, 7, p. 1122-1127 6 p.Research output: Contribution to journal › Article
- Published
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: Results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
Robert Hills, Keith Wheatley, 1 Jan 2013, In: Leukemia. 27, 1, p. 75-81 7 p.Research output: Contribution to journal › Article › peer-review
- Published
The impact of SF3B1 mutations in CLL on the DNA-damage response
Ceri Oldreive, Tatjana Stankovic, May 2015, In: Leukemia. 29, 5, p. 1133-42 10 p.Research output: Contribution to journal › Article › peer-review
- Published
- Published
The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukaemia
Dickens Pratt, 8 Jun 2006, In: Leukemia. 20, p. 1460-1461 2 p.Research output: Contribution to journal › Letter
- E-pub ahead of print
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia
Pamela Kearns, 20 Mar 2018, In: Leukemia. 10 p.Research output: Contribution to journal › Article › peer-review
- Published
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
Keith Wheatley, Oct 2010, In: Leukemia. 24, 10, p. 1700-12 13 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3
Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, In: Leukemia.Research output: Contribution to journal › Article › peer-review
- Published
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
McNeill Hayden, Dickens Pratt, Nick Davies, Farhat Khanim, Mark Drayson & Christopher Bunce, 1 Feb 2009, In: Leukemia. 23, 2, p. 292-304 13 p.Research output: Contribution to journal › Article
- Published
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
Keith Wheatley, Robert Hills, 1 Dec 2005, In: Leukemia. 19, p. 2130-2138 9 p.Research output: Contribution to journal › Article